# STP206 for the Prevention of Necrotizing Enterocolitis (NEC)

> **NCT01954017** · PHASE1 · COMPLETED · sponsor: **Leadiant Biosciences, Inc.** · enrollment: 103 (actual)

## Conditions studied

- Necrotizing Enterocolitis

## Interventions

- **BIOLOGICAL:** STP206
- **OTHER:** Control

## Key facts

- **NCT ID:** NCT01954017
- **Lead sponsor:** Leadiant Biosciences, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01-30
- **Primary completion:** 2018-02-28
- **Final completion:** 2018-10-22
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2020-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01954017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01954017, "STP206 for the Prevention of Necrotizing Enterocolitis (NEC)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01954017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*